Erratum: Correction: Smart soup, a traditional Chinese medicine formula, ameliorates amyloid pathology and related cognitive deficits (PLoS ONE (2014) 9:11 (e111215) DOI: 10.1371/journal.pone.0111215);Smart soup, a traditional Chinese medicine formula, ameliorates amyloid pathology and related cognitive deficits

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Hou, Yujun ^a   Wang, Ying ^b   Zhao, Jian ^a   Li, Xiaohang ^a   Cui, Jin ^a   Ding, Jianqing ^b   Zeng, Xianglu ^a   Ling, Yun ^c   Shen, Xiaoheng ^b   Chen, Shengdi ^b   Huang, Chenggang ^c   Pei, Gang ^a,d  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^d TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; HERBACEOUS AGENT; SMART SOUP; UNCLASSIFIED DRUG; BETA-AMYLOID PRECURSOR PROTEIN KINASE I; NEUROPROTECTIVE AGENT; PLANT MEDICINAL PRODUCT; PROTEIN SERINE THREONINE KINASE;

ACORI TATARINOWII; ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHINESE MEDICINE; COGNITIVE DEFECT; CONTROLLED STUDY; DEATH; DRUG EFFICACY; GLIOSIS; LOCOMOTION; MEDICINAL PLANT; MOTOR DYSFUNCTION; MOUSE; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; PORIA CUM RADIX PINI; RADIX POLYGALAE; AMYLOID NEUROPATHIES; ANIMAL; C57BL MOUSE; CELL CULTURE; COGNITION DISORDERS; DISEASE MODEL; DROSOPHILA; DRUG EFFECTS; GENETICS; MAZE TEST; METABOLISM; NERVE CELL; PATHOLOGY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID NEUROPATHIES; ANIMALS; CELLS, CULTURED; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; DROSOPHILA; GLIOSIS; MAZE LEARNING; MEDICINE, CHINESE TRADITIONAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONS; NEUROPROTECTIVE AGENTS; PLANT PREPARATIONS; PROTEIN-SERINE-THREONINE KINASES;

EID: 84911939122     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0237035     Document Type: Erratum

References (47)

1. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353-356.
2. Selkoe DJ (2002) Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease. The Journal of clinical investigation 110:1375-1381.
3. Selkoe DJ (1997) Alzheimer's disease: genotypes, phenotypes, and treatments. Science 275:630-631.
4. Winslow BT, Onysko MK, Stob CM, Hazlewood KA (2011) Treatment of Alzheimer disease. American family physician 83:1403-1412.
5. Howes MJ, Houghton PJ (2003) Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function. Pharmacology, biochemistry, and behavior 75:513-527.
6. Tian XY, Liu L (2012) Drug discovery enters a new era with multi-target intervention strategy. Chinese journal of integrative medicine 18:539-542.
7. Lee B, Choi Y, Kim H, Kim SY, Hahm DH, et al. (2003) Protective effects of methanol extract of Acori graminei rhizoma and Uncariae Ramulus et Uncus on ischemia-induced neuronal death and cognitive impairments in the rat. Life sciences 74:435-450.
8. Tong XG, Liu JL, Cheng YX (2010) A new pregnane steroid from Poria cum radix pini. Journal of Asian natural products research 12:419-423.
9. Chen YL, Hsieh CL, Wu PH, Lin JG (2004) Effect of Polygala tenuifolia root on behavioral disorders by lesioning nucleus basalis magnocellularis in rat. Journal of ethnopharmacology 95:47-55.
10. Park CH, Choi SH, Koo JW, Seo JH, Kim HS, et al. (2002) Novel cognitive improving and neuroprotective activities of Polygala tenuifolia Willdenow extract, BT-11. Journal of neuroscience research 70:484-492.
11. Lin Z, Gu J, Xiu J, Mi T, Dong J, et al. (2012) Traditional chinese medicine for senile dementia. Evidence-based complementary and alternative medicine: eCAM 2012:692621.
12. Lee JY, Kim KY, Shin KY, Won BY, Jung HY, et al. (2009) Effects of BT-11 on memory in healthy humans. Neuroscience letters 454:111-114.
13. Shin KY, Lee JY, Won BY, Jung HY, Chang KA, et al. (2009) BT-11 is effective for enhancing cognitive functions in the elderly humans. Neuroscience letters 465:157-159.
14. Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, et al. (2001) Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomolecular engineering 17:157-165.
15. Reiserer RS, Harrison FE, Syverud DC, McDonald MP (2007) Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease. Genes, brain, and behavior 6:54-65.
16. Bero AW, Yan P, Roh JH, Cirrito JR, Stewart FR, et al. (2011) Neuronal activity regulates the regional vulnerability to amyloid-beta deposition. Nature neuroscience 14:750-756.
17. Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. Journal of neuroscience methods 11:47-60.
18. Alamed J, Wilcock DM, Diamond DM, Gordon MN, Morgan D (2006) Twoday radial-arm water maze learning and memory task; robust resolution of amyloid-related memory deficits in transgenic mice. Nature protocols 1:1671-1679.
19. Teng L, Zhao J, Wang F, Ma L, Pei G (2010) A GPCR/secretase complex regulates beta- and gamma-secretase specificity for Abeta production and contributes to AD pathogenesis. Cell research 20:138-153.
20. Bevins RA, Besheer J (2006) Object recognition in rats and mice: a one-trial nonmatching-to-sample learning task to study 'recognition memory'. Nature protocols 1:1306-1311.
21. Liu X, Zhao X, Zeng X, Bossers K, Swaab DF, et al. (2013) beta-arrestin1 regulates gamma-secretase complex assembly and modulates amyloid-beta pathology. Cell research 23:351-365.
22. Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, et al. (2005) Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 120:701-713.
23. Chakraborty R, Vepuri V, Mhatre SD, Paddock BE, Miller S, et al. (2011) Characterization of a Drosophila Alzheimer's disease model: pharmacological rescue of cognitive defects. PloS one 6:e20799.
24. Brand AH, Perrimon N (1993) Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118:401-415.
25. Zhao XL, Wang WA, Tan JX, Huang JK, Zhang X, et al. (2010) Expression of beta-amyloid induced age-dependent presynaptic and axonal changes in Drosophila. The Journal of neuroscience: the official journal of the Society for Neuroscience 30:1512-1522.
26. White KE, Humphrey DM, Hirth F (2010) The dopaminergic system in the aging brain of Drosophila. Frontiers in neuroscience 4:205.
27. Mhatre SD, Satyasi V, Killen M, Paddock BE, Moir RD, et al. (2014) Synaptic abnormalities in a Drosophila model of Alzheimer's disease. Disease models & mechanisms 7:373-385.
28. Stine WB Jr, Dahlgren KN, Krafft GA, La Du MJ (2003) In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. The Journal of biological chemistry 278:11612-11622.
29. Lu JH, Ardah MT, Durairajan SS, Liu LF, Xie LX, et al. (2011) Baicalein inhibits formation of alpha-synuclein oligomers within living cells and prevents Abeta peptide fibrillation and oligomerisation. Chembiochem: a European journal of chemical biology 12:615-624.
30. Cartier AE, Djakovic SN, Salehi A, Wilson SM, Masliah E, et al. (2009) Regulation of synaptic structure by ubiquitin C-terminal hydrolase L1. The Journal of neuroscience: the official journal of the Society for Neuroscience 29:7857-7868.
31. Cisse M, Halabisky B, Harris J, Devidze N, Dubal DB, et al. (2011) Reversing EphB2 depletion rescues cognitive functions in Alzheimer model. Nature 469:47-52.
32. Ling Y, Li Z, Chen M, Sun Z, Fan M, et al. (2013) Analysis of multiple constituents in Cong-Ming-Tang, a Chinese herbal formula for the treatment of amnesia, by high-performance liquid chromatography with quadrupole time-offlight mass spectrometry. Phytochemical analysis: PCA 24:677-688.
33. Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, et al. (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Human molecular genetics 13:159-170.
34. Cao D, Lu H, Lewis TL, Li L (2007) Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. The Journal of biological chemistry 282:36275-36282.
35. Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, et al. (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440:352-357.
36. Walsh DM, Selkoe DJ (2007) A beta oligomers - a decade of discovery. Journal of neurochemistry 101:1172-1184.
37. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, et al. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal longterm potentiation in vivo. Nature 416:535-539.
38. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, et al. (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nature medicine 14:837-842.
39. Cheng IH, Scearce-Levie K, Legleiter J, Palop JJ, Gerstein H, et al. (2007) Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. The Journal of biological chemistry 282:23818-23828.
40. Lesne S, Kotilinek L, Ashe KH (2008) Plaque-bearing mice with reduced levels of oligomeric amyloid-beta assemblies have intact memory function. Neuroscience 151:745-749.
41. McGeer EG, McGeer PL (2003) Inflammatory processes in Alzheimer's disease. Progress in neuro-psychopharmacology & biological psychiatry 27:741-749.
42. Kraft AW, Hu X, Yoon H, Yan P, Xiao Q, et al. (2012) Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice. FASEB journal: official publication of the Federation of American Societies for Experimental Biology.
43. Hamilton A, Holscher C (2012) The effect of ageing on neurogenesis and oxidative stress in the APP (swe)/PS1 (deltaE9) mouse model of Alzheimer's disease. Brain research 1449:83-93.
44. Muqit MM, Feany MB (2002) Modelling neurodegenerative diseases in Drosophila: a fruitful approach? Nature reviews Neuroscience 3:237-243.
45. Bilen J, Bonini NM (2005) Drosophila as a model for human neurodegenerative disease. Annual review of genetics 39:153-171.
46. Iijima K, Iijima-Ando K (2008) Drosophila models of Alzheimer's amyloidosis: the challenge of dissecting the complex mechanisms of toxicity of amyloid-beta 42. Journal of Alzheimer's disease: JAD 15:523-540.
47. Dahlgren KN, Manelli AM, Stine WB Jr, Baker LK, Krafft GA, et al. (2002) Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. The Journal of biological chemistry 277:32046-32053.